Axcelead is capable of offering one-stop solution for molecular glue degraders and bifunctional degrader drug discovery, leveraging our proprietary end-to-end platform. Axcelead’s distinctive solution for molecular glue degraders is characterized by the selective molecular glue degrader creation, utilizing its unique focused library, neo-substrate identification technology, and comprehensive selectivity evaluation. The most distinctive feature of the Axcelead’s bifunctional degrader drug discovery solution is its multi-step high-throughput synthesis technology using the Degrader chemical toolbox, and rapid ADME problem-solving technology. Moreover, Axcelead’s basic platforms are also well-developed to accelerate all stages of TPD drug discovery. These platforms include screening, compound profiling and mechanism identification. Please feel free to reach out to us to discover further information about our TPD drug discovery!